{"id":832541,"date":"2026-07-29T00:42:24","date_gmt":"2026-07-29T00:42:24","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/832541\/"},"modified":"2026-07-29T00:42:24","modified_gmt":"2026-07-29T00:42:24","slug":"apotex-emerges-as-only-supplier-of-generic-ozempic-in-canada-for-now","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/832541\/","title":{"rendered":"Apotex emerges as only supplier of generic Ozempic in Canada for now"},"content":{"rendered":"<p class=\"c-article-body__text text-pr-5\">Apotex Health Corp. <a href=\"https:\/\/www.theglobeandmail.com\/investing\/markets\/stocks\/APTX-T\/\" target=\"_blank\" rel=\"noreferrer nofollow noopener\" title=\"https:\/\/www.theglobeandmail.com\/investing\/markets\/stocks\/APTX-T\/\">APTX-T<\/a> has emerged as the only maker of generic Ozempic for Canadians for at least the next few months after a manufacturing issue at an Indian plant sidelined at least two competitors.<\/p>\n<p class=\"c-article-body__text text-pr-5\">Ozempic, the brand name of the drug semaglutide made by Danish drug maker Novo Nordisk <a href=\"https:\/\/www.theglobeandmail.com\/investing\/markets\/stocks\/NVO-N\/\" target=\"_blank\" rel=\"noreferrer nofollow noopener\" title=\"https:\/\/www.theglobeandmail.com\/investing\/markets\/stocks\/NVO-N\/\">NVO-N<\/a>, was the highest-selling drug in Canada last year with $2.9-billion in sales, according to aggregated prescription data collected by IQVIA Canada, an analytics company. <\/p>\n<p class=\"c-article-body__text text-pr-5\">Ozempic is authorized for patients with type-2 diabetes, while a higher-dose formulation sold under the name Wegovy is authorized for weight management. More than one million Canadians took semaglutide last year.<\/p>\n<p class=\"c-article-body__text text-pr-5\">Generic forms of semaglutide became legal in January after Novo Nordisk\u2019s <a href=\"https:\/\/www.theglobeandmail.com\/business\/economy\/article-generic-ozempic-canada-drugmakers\/\" target=\"_self\" rel=\"nofollow noopener\" title=\"https:\/\/www.theglobeandmail.com\/business\/economy\/article-generic-ozempic-canada-drugmakers\/\">remaining market protections expired<\/a>, and Health Canada began issuing approvals in late April: first for a generic manufactured by India\u2019s Dr. Reddy\u2019s Laboratories Ltd. and then for another made by Toronto-based Apotex Health Corp. South Africa\u2019s Aspen Pharmacare Holdings Ltd. <a href=\"https:\/\/www.theglobeandmail.com\/investing\/markets\/stocks\/APNHY\/\" target=\"_blank\" rel=\"noreferrer nofollow noopener\" title=\"https:\/\/www.theglobeandmail.com\/investing\/markets\/stocks\/APNHY\/\">APNHY<\/a> was approved July 17.<\/p>\n<p class=\"c-article-body__text text-pr-5\">But earlier this month, Dr. Reddy\u2019s disclosed to Indian investors that it discovered problems at a facility it was upgrading to produce more semaglutide to meet growing global demand for the drug.<\/p>\n<p class=\"c-article-body__text mv-16 l-inset text-pb-8\" data-sophi-feature=\"interstitial\"><a href=\"https:\/\/www.theglobeandmail.com\/canada\/article-generic-semaglutide-ozempic-canada-availability-price-insurance\/\" rel=\"nofollow noopener\" target=\"_blank\">Generic semaglutide is now available in Canada. Where is the medication available and is it actually cheaper?<\/a><\/p>\n<p class=\"c-article-body__text text-pr-5\">Erez Israeli, Dr. Reddy\u2019s chief executive officer, told analysts on a July 9 call that the company found the level of impurities in the pharmaceutical ingredients produced at the facility were \u201cout of specifications.\u201d<\/p>\n<p class=\"c-article-body__text text-pr-5\">He said it would take until late October or early November to fix the issues and finish testing, although he warned there was a risk of further delays.<\/p>\n<p class=\"c-article-body__text text-pr-5\">Mr. Israeli said there was no recall concern because the supply of semaglutide sent to Canada did not come from the faulty batches. \u201cAnything that was sent to the market is safe,\u201d he said on the call.<\/p>\n<p class=\"c-article-body__text text-pr-5\">Health Canada did not answer a question Tuesday about whether it had any concerns about Dr. Reddy\u2019s semaglutide.<\/p>\n<p class=\"c-article-body__text text-pr-5\">The manufacturing issue has also left Aspen in the lurch, which had been authorized to sell semaglutide through a licensing deal with Dr. Reddy\u2019s. The company said in a notice last week that the timing of its launch will depend on the availability of semaglutide produced by Dr. Reddy\u2019s.<\/p>\n<p class=\"c-article-body__text text-pr-5\">That has left Apotex as the only supplier of generic semaglutide in Canada for now.<\/p>\n<p class=\"c-article-body__text mv-16 l-inset text-pb-8\" data-sophi-feature=\"interstitial\"><a href=\"https:\/\/www.theglobeandmail.com\/business\/economy\/article-apotex-ipo-securities-filing-5-billion-valuation-june-1\/\" rel=\"nofollow noopener\" target=\"_blank\">Apotex\u2019s planned IPO values generic drug maker at $5-billion<\/a><\/p>\n<p class=\"c-article-body__text text-pr-5\">\u201cWhile we didn\u2019t anticipate being the only generic available, we continue to work with our partners to increase our supply as we understand there remains a very strong demand, particularly as the product is now available at a fraction of the cost it was previously,\u201d said Catherine Thomas, Apotex\u2019s vice-president of global communications.<\/p>\n<p class=\"c-article-body__text text-pr-5\">Key ingredients for Apotex\u2019s semaglutide are also produced in India, through a partnership with Indian pharmaceutical company Orbicular Pharmaceutical Technologies.<\/p>\n<p class=\"c-article-body__text text-pr-5\">David Martin, managing director and head of equity research at Bloom Burton Securities Inc., said this was \u201cgood news in the short-term for Apotex.\u201d<\/p>\n<p class=\"c-article-body__text text-pr-5\">Bloom Burton had forecasted the sales of Apotex\u2019s semaglutide in Canada to be $124.4-million for the fiscal year ending March 31, 2027, but that assumed the generic market would be split with Dr. Reddy\u2019s.<\/p>\n<p class=\"c-article-body__text text-pr-5\">Fewer generic options also may be a boon for name-brand Ozempic.<\/p>\n<p class=\"c-article-body__text text-pr-5\">Generic drugs tend to attract patients by offering lower prices. In Canada, generic prices are set out in a formula agreed to by insurance plans and drug makers. For injectable drugs where there are at least three manufacturers on the market, prices have a ceiling of 35 per cent of the name brand price.<\/p>\n<p class=\"c-article-body__text mv-16 l-inset text-pb-8\" data-sophi-feature=\"interstitial\"><a href=\"https:\/\/www.theglobeandmail.com\/canada\/article-generic-wegovy-semaglutide-canada\/\" rel=\"nofollow noopener\" target=\"_blank\">First generic semaglutide for weight loss gets Health Canada approval<\/a><\/p>\n<p class=\"c-article-body__text text-pr-5\">The current list price of name-brand Ozempic is $228 for a four-week supply, while the products from Apotex and Dr. Reddy\u2019s are priced at $78. Those prices are before markups from pharmacies and distributors, but also before any manufacturer discounts.<\/p>\n<p class=\"c-article-body__text text-pr-5\">As generics have come on the market in recent months, Novo Nordisk has announced discount cards that would allow patients outside of Quebec, who are paying out of pocket or through private insurance, to pay generic prices for Ozempic.<\/p>\n<p class=\"c-article-body__text text-pr-5\">Kate Hanna, director of communications at Novo Nordisk Canada, said the company could not share data on how many patients have stayed on the brand name. <\/p>\n<p class=\"c-article-body__text text-pr-5\">She said Novo Nordisk has an established, stable supply of Ozempic for the Canadian market.<\/p>\n<p class=\"c-article-body__text text-pr-5\">Most pharmacies and distributors contacted by The Globe and Mail said they have not yet seen any major disruptions to the supply of semaglutide, but are monitoring the situation.<\/p>\n<p class=\"c-article-body__text text-pr-5\">\u201cWe work closely with all manufacturers of this therapy, and at this time we\u2019re receiving adequate supply of semaglutide to support our patients,\u201d said Youmna Rab, retail communications manager at Loblaw Companies Ltd.<\/p>\n<p class=\"c-article-body__text text-pr-5\">Tom Elliott, medical director of BCDiabetes, a large clinic for people with diabetes in Vancouver, said his patients have had limited access to generic semaglutide so far and are sticking to the brand name.<\/p>\n","protected":false},"excerpt":{"rendered":"Apotex Health Corp. APTX-T has emerged as the only maker of generic Ozempic for Canadians for at least&hellip;\n","protected":false},"author":2,"featured_media":832542,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[901,888,902,879,877,903,49,48,876,895,896,891,878,875,46,549,295,894,887,914,880,881,893,889,890,884,904,885,909,910,44,912,907,911,905,908,882,898,899,714,897,906,865,61,900,892,886,883,913],"class_list":["post-832541","post","type-post","status-publish","format-standard","has-post-thumbnail","category-canada","tag-alberta","tag-arts-news","tag-bc","tag-breaking-news","tag-breaking-news-video","tag-british-columbia","tag-ca","tag-canada","tag-canada-news","tag-canada-sports","tag-canada-sports-news","tag-canada-trafficcanada-weather","tag-canadian-breaking-news","tag-canadian-news","tag-economy","tag-education","tag-environment","tag-federal-government","tag-foreign-news","tag-globe-and-mail","tag-globe-and-mail-breaking-news","tag-globe-and-mail-canada-news","tag-government","tag-life-news","tag-lifestyle","tag-local-news","tag-manitoba","tag-national-news","tag-new-brunswick","tag-newfoundland-and-labrador","tag-news","tag-northwest-territories","tag-nova-scotia","tag-nunavut","tag-ontario","tag-pei","tag-photos","tag-political-news","tag-political-opinion","tag-politics","tag-politics-news","tag-quebec","tag-sports-news","tag-technology","tag-travel","tag-trudeau","tag-us-news","tag-world-news","tag-yukon"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/832541","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=832541"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/832541\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/832542"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=832541"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=832541"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=832541"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}